

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.69818792 |
| 2 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.62485586 |
| 3 | regulation of gene silencing by miRNA (GO:0060964) | 5.62485586 |
| 4 | regulation of gene silencing by RNA (GO:0060966) | 5.62485586 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.17686363 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.93749122 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.93749122 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.93749122 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.93749122 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.93749122 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.93749122 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.75621702 |
| 13 | response to peptidoglycan (GO:0032494) | 4.75201837 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.68454844 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.68454844 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.64696533 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.62126725 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58985087 |
| 19 | urate metabolic process (GO:0046415) | 4.35360112 |
| 20 | detection of other organism (GO:0098543) | 4.30876371 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.28275310 |
| 22 | detection of bacterium (GO:0016045) | 4.06012236 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04281661 |
| 24 | modified amino acid transport (GO:0072337) | 4.01131768 |
| 25 | drug transport (GO:0015893) | 4.00837962 |
| 26 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.99272992 |
| 27 | folic acid metabolic process (GO:0046655) | 3.97002672 |
| 28 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.90507358 |
| 29 | intestinal absorption (GO:0050892) | 3.89064254 |
| 30 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.87921713 |
| 31 | drug transmembrane transport (GO:0006855) | 3.86506035 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84919504 |
| 33 | cellular extravasation (GO:0045123) | 3.81309919 |
| 34 | nucleobase biosynthetic process (GO:0046112) | 3.78788064 |
| 35 | lysine metabolic process (GO:0006553) | 3.78302603 |
| 36 | lysine catabolic process (GO:0006554) | 3.78302603 |
| 37 | peptide catabolic process (GO:0043171) | 3.77757406 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.67104607 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 3.65124553 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.63416180 |
| 41 | purine nucleobase biosynthetic process (GO:0009113) | 3.61998658 |
| 42 | neutrophil activation (GO:0042119) | 3.59653033 |
| 43 | granulocyte activation (GO:0036230) | 3.57136099 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56873479 |
| 45 | positive regulation of mast cell activation (GO:0033005) | 3.56824760 |
| 46 | histone arginine methylation (GO:0034969) | 3.56055256 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53966400 |
| 48 | regulation of mast cell degranulation (GO:0043304) | 3.51791861 |
| 49 | renal absorption (GO:0070293) | 3.51615403 |
| 50 | phosphate ion transport (GO:0006817) | 3.46575560 |
| 51 | respiratory burst (GO:0045730) | 3.45677091 |
| 52 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.45407289 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45276237 |
| 54 | angiotensin maturation (GO:0002003) | 3.43582524 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.41844724 |
| 56 | phospholipid efflux (GO:0033700) | 3.41587262 |
| 57 | anterior/posterior axis specification, embryo (GO:0008595) | 3.40624884 |
| 58 | macrophage activation (GO:0042116) | 3.40340856 |
| 59 | DNA unwinding involved in DNA replication (GO:0006268) | 3.38719428 |
| 60 | microglial cell activation (GO:0001774) | 3.35187097 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33711951 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.32318613 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30700379 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.30515858 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.30300796 |
| 66 | formation of translation preinitiation complex (GO:0001731) | 3.27449974 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26452131 |
| 68 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.25991209 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24137099 |
| 70 | ribosome assembly (GO:0042255) | 3.23203563 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 3.22377930 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.22377930 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 3.20378045 |
| 74 | glycosphingolipid catabolic process (GO:0046479) | 3.19910128 |
| 75 | IMP biosynthetic process (GO:0006188) | 3.19235675 |
| 76 | maturation of SSU-rRNA (GO:0030490) | 3.19212891 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.18920644 |
| 78 | drug catabolic process (GO:0042737) | 3.17934856 |
| 79 | B cell mediated immunity (GO:0019724) | 3.17693844 |
| 80 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.16958092 |
| 81 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16927419 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16733993 |
| 83 | response to host immune response (GO:0052572) | 3.16733993 |
| 84 | phosphate ion transmembrane transport (GO:0035435) | 3.16061695 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 3.15505743 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.12691477 |
| 87 | negative regulation of gene silencing (GO:0060969) | 3.10021632 |
| 88 | oligosaccharide catabolic process (GO:0009313) | 3.07639216 |
| 89 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07045820 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 3.04182894 |
| 91 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.03505070 |
| 92 | nuclear pore organization (GO:0006999) | 3.02280814 |
| 93 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01798060 |
| 94 | DNA replication initiation (GO:0006270) | 3.00423637 |
| 95 | T-helper 1 type immune response (GO:0042088) | 2.98860573 |
| 96 | trophectodermal cell differentiation (GO:0001829) | 2.98791516 |
| 97 | nodal signaling pathway (GO:0038092) | 2.98762036 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98247348 |
| 99 | vitamin D metabolic process (GO:0042359) | 2.97589731 |
| 100 | positive regulation of leukocyte degranulation (GO:0043302) | 2.96285693 |
| 101 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.94305395 |
| 102 | glycolipid catabolic process (GO:0019377) | 2.92901703 |
| 103 | protein complex localization (GO:0031503) | 2.92828167 |
| 104 | defense response to protozoan (GO:0042832) | 2.91493076 |
| 105 | regulation of tolerance induction (GO:0002643) | 2.91353647 |
| 106 | embryonic process involved in female pregnancy (GO:0060136) | 2.89271941 |
| 107 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.88339089 |
| 108 | proline metabolic process (GO:0006560) | 2.87890422 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 2.87640138 |
| 110 | cellular response to type I interferon (GO:0071357) | 2.87515475 |
| 111 | type I interferon signaling pathway (GO:0060337) | 2.87515475 |
| 112 | leukocyte aggregation (GO:0070486) | 2.87093532 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 2.86989791 |
| 114 | regulation of gene silencing (GO:0060968) | 2.86423026 |
| 115 | intestinal cholesterol absorption (GO:0030299) | 2.84666187 |
| 116 | response to type I interferon (GO:0034340) | 2.83875765 |
| 117 | response to host defenses (GO:0052200) | 2.83774684 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83774684 |
| 119 | response to host (GO:0075136) | 2.83774684 |
| 120 | ribosomal large subunit biogenesis (GO:0042273) | 2.83739551 |
| 121 | DNA strand elongation (GO:0022616) | 2.83371581 |
| 122 | organic cation transport (GO:0015695) | 2.81474278 |
| 123 | mitotic nuclear envelope disassembly (GO:0007077) | 2.81391195 |
| 124 | NIK/NF-kappaB signaling (GO:0038061) | 2.81376666 |
| 125 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.80420913 |
| 126 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.80420913 |
| 127 | paraxial mesoderm development (GO:0048339) | 2.80327752 |
| 128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.79142664 |
| 129 | negative regulation of interleukin-1 production (GO:0032692) | 2.79044607 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.78979404 |
| 131 | homocysteine metabolic process (GO:0050667) | 2.77952543 |
| 132 | mitotic metaphase plate congression (GO:0007080) | 2.77804047 |
| 133 | folic acid-containing compound metabolic process (GO:0006760) | 2.77522243 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77254087 |
| 135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.76355369 |
| 136 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76259872 |
| 137 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.75922097 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.75725738 |
| 139 | heterochromatin organization (GO:0070828) | 2.75428823 |
| 140 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75030819 |
| 141 | response to hepatocyte growth factor (GO:0035728) | 2.74983967 |
| 142 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.74983967 |
| 143 | response to protozoan (GO:0001562) | 2.73817960 |
| 144 | amino sugar catabolic process (GO:0046348) | 2.73175966 |
| 145 | germinal center formation (GO:0002467) | 2.73160116 |
| 146 | serine family amino acid biosynthetic process (GO:0009070) | 2.71432514 |
| 147 | IMP metabolic process (GO:0046040) | 2.71083043 |
| 148 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.70815269 |
| 149 | myeloid leukocyte activation (GO:0002274) | 2.69123743 |
| 150 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68985879 |
| 151 | regulation of regulated secretory pathway (GO:1903305) | 2.68750189 |
| 152 | regulation of cholesterol esterification (GO:0010872) | 2.68259054 |
| 153 | interferon-gamma secretion (GO:0072643) | 2.67664197 |
| 154 | folic acid transport (GO:0015884) | 2.66851452 |
| 155 | tetrahydrofolate metabolic process (GO:0046653) | 2.66508102 |
| 156 | protein-lipid complex assembly (GO:0065005) | 2.64750058 |
| 157 | regulation of protein heterodimerization activity (GO:0043497) | 2.64580234 |
| 158 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64350440 |
| 159 | viral transcription (GO:0019083) | 2.63499191 |
| 160 | glycoside metabolic process (GO:0016137) | 2.63360337 |
| 161 | neutrophil mediated immunity (GO:0002446) | 2.62785578 |
| 162 | vitamin transport (GO:0051180) | 2.62405561 |
| 163 | nuclear pore complex assembly (GO:0051292) | 2.62169754 |
| 164 | regulation of mononuclear cell migration (GO:0071675) | 2.62151467 |
| 165 | nuclear envelope disassembly (GO:0051081) | 2.59459689 |
| 166 | membrane disassembly (GO:0030397) | 2.59459689 |
| 167 | adhesion of symbiont to host cell (GO:0044650) | 2.59297334 |
| 168 | virion attachment to host cell (GO:0019062) | 2.59297334 |
| 169 | regulation of translational fidelity (GO:0006450) | 2.59079215 |
| 170 | serine family amino acid metabolic process (GO:0009069) | 2.58749704 |
| 171 | regulation of hippo signaling (GO:0035330) | 2.58313575 |
| 172 | translational termination (GO:0006415) | 2.58275068 |
| 173 | intestinal epithelial cell development (GO:0060576) | 2.57896509 |
| 174 | regulation of histone H3-K9 methylation (GO:0051570) | 2.56589927 |
| 175 | toxin transport (GO:1901998) | 2.56390900 |
| 176 | basic amino acid transport (GO:0015802) | 2.55929039 |
| 177 | regulation of helicase activity (GO:0051095) | 2.54073183 |
| 178 | sulfur compound transport (GO:0072348) | 2.52606663 |
| 179 | determination of adult lifespan (GO:0008340) | 2.52321302 |
| 180 | cysteine metabolic process (GO:0006534) | 2.50651564 |
| 181 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.47459317 |
| 182 | translational elongation (GO:0006414) | 2.47439176 |
| 183 | pre-miRNA processing (GO:0031054) | 2.47319566 |
| 184 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.46883312 |
| 185 | excretion (GO:0007588) | 2.44888288 |
| 186 | nucleoside salvage (GO:0043174) | 2.44711710 |
| 187 | purine nucleotide salvage (GO:0032261) | 2.42469023 |
| 188 | exogenous drug catabolic process (GO:0042738) | 2.41956434 |
| 189 | pteridine-containing compound metabolic process (GO:0042558) | 2.41907821 |
| 190 | glycine metabolic process (GO:0006544) | 2.37921641 |
| 191 | ribosome biogenesis (GO:0042254) | 2.37345388 |
| 192 | cytidine deamination (GO:0009972) | 2.36876923 |
| 193 | cytidine metabolic process (GO:0046087) | 2.36876923 |
| 194 | cytidine catabolic process (GO:0006216) | 2.36876923 |
| 195 | translational initiation (GO:0006413) | 2.36172045 |
| 196 | metaphase plate congression (GO:0051310) | 2.35797717 |
| 197 | regulation of translational termination (GO:0006449) | 2.35526134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.48323815 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.87300108 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67540112 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.46096675 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.30109340 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22171295 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17465382 |
| 8 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.10837861 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96102399 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93438207 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92033910 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.72083044 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.72083044 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.72083044 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.66699377 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63479803 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63381688 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.61822691 |
| 19 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.46354131 |
| 20 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.43805890 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.41452202 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38044547 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.37520892 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.36068115 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35386466 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34338737 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.29607219 |
| 28 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.28849006 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.26796456 |
| 30 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.21728556 |
| 31 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.20173684 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.19987876 |
| 33 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15361045 |
| 34 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.10567543 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08866611 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04289861 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03999730 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03986078 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.02262022 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.93893674 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92570473 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.90492412 |
| 43 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.89701955 |
| 44 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.89254469 |
| 45 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.88131740 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87916287 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.87743871 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82141371 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81530971 |
| 50 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.77831728 |
| 51 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.74944808 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73773511 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73643979 |
| 54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.67307989 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64733560 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.64638802 |
| 57 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63406097 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60339118 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60263645 |
| 60 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.58664932 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.58175196 |
| 62 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57899611 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57436216 |
| 64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55855059 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55254472 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52277686 |
| 67 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.51433393 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51167137 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.51093292 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49136476 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.49073085 |
| 72 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.48571240 |
| 73 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47925219 |
| 74 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.45910532 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45488023 |
| 76 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.44397870 |
| 77 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.44198463 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44144599 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 1.43500992 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42269995 |
| 81 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37785426 |
| 82 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.37684894 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37209340 |
| 84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34989265 |
| 85 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34481062 |
| 86 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.34419324 |
| 87 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.33269469 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32758777 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.32745317 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32131530 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31305214 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31215953 |
| 93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30490945 |
| 94 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.30268134 |
| 95 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29041807 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28868876 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28691867 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27074187 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26631366 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26459548 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26411122 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25227013 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24694936 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21641262 |
| 105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20783639 |
| 106 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19518872 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18923372 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18738880 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18493387 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18407826 |
| 111 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.18219476 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18000118 |
| 113 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.17592978 |
| 114 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17269347 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16460642 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16180443 |
| 117 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16099653 |
| 118 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15946232 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15460444 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14864760 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14660069 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14615385 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14096286 |
| 124 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14047363 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13833950 |
| 126 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.11502267 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10622812 |
| 128 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.09251227 |
| 129 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09147216 |
| 130 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.08514895 |
| 131 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08405618 |
| 132 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08212418 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08194541 |
| 134 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08172504 |
| 135 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08150414 |
| 136 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08000777 |
| 137 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07995508 |
| 138 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07568919 |
| 139 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07531928 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07531492 |
| 141 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06449266 |
| 142 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05781203 |
| 143 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.05735771 |
| 144 | MAF_26560356_Chip-Seq_TH2_Human | 1.05514433 |
| 145 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05335400 |
| 146 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04701951 |
| 147 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04615916 |
| 148 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04494670 |
| 149 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04412222 |
| 150 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04382425 |
| 151 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.02189000 |
| 152 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00594177 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00497314 |
| 154 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98346203 |
| 155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97835932 |
| 156 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97239859 |
| 157 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96849318 |
| 158 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96735775 |
| 159 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96565443 |
| 160 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96361617 |
| 161 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95018699 |
| 162 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.94693771 |
| 163 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93821315 |
| 164 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93609521 |
| 165 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93371944 |
| 166 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.93041159 |
| 167 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92907754 |
| 168 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92731936 |
| 169 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92258034 |
| 170 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92110162 |
| 171 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91703362 |
| 172 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91527371 |
| 173 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91477218 |
| 174 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.91191268 |
| 175 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90294891 |
| 176 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.89561579 |
| 177 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89220881 |
| 178 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88295376 |
| 179 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87541521 |
| 180 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87433093 |
| 181 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87340585 |
| 182 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86329540 |
| 183 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79552772 |
| 184 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79044337 |
| 185 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78169094 |
| 186 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73678356 |
| 187 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72727825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.26808113 |
| 2 | MP0003724_increased_susceptibility_to | 3.87002327 |
| 3 | MP0003303_peritoneal_inflammation | 3.78486074 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.31134690 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.92864112 |
| 6 | MP0009785_altered_susceptibility_to | 2.92665110 |
| 7 | MP0002419_abnormal_innate_immunity | 2.90686933 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.86471178 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.77588930 |
| 10 | MP0005671_abnormal_response_to | 2.71606315 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.67517045 |
| 12 | MP0001790_abnormal_immune_system | 2.64118549 |
| 13 | MP0005387_immune_system_phenotype | 2.64118549 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.63876249 |
| 15 | MP0005025_abnormal_response_to | 2.60439589 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.53984997 |
| 17 | MP0001800_abnormal_humoral_immune | 2.37540193 |
| 18 | MP0000685_abnormal_immune_system | 2.36556821 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.28180740 |
| 20 | MP0009840_abnormal_foam_cell | 2.26770993 |
| 21 | MP0002723_abnormal_immune_serum | 2.23023221 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.16812841 |
| 23 | MP0004133_heterotaxia | 2.15357903 |
| 24 | * MP0005332_abnormal_amino_acid | 2.13447680 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 2.11576014 |
| 26 | MP0003878_abnormal_ear_physiology | 2.07098716 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 2.07098716 |
| 28 | * MP0009643_abnormal_urine_homeostasis | 2.04429894 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.01311331 |
| 30 | MP0001819_abnormal_immune_cell | 2.00883097 |
| 31 | MP0001533_abnormal_skeleton_physiology | 2.00306440 |
| 32 | MP0004043_abnormal_pH_regulation | 1.99948602 |
| 33 | MP0000604_amyloidosis | 1.96766765 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.93913317 |
| 35 | MP0003111_abnormal_nucleus_morphology | 1.91798648 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.89437087 |
| 37 | MP0003077_abnormal_cell_cycle | 1.87381033 |
| 38 | MP0002136_abnormal_kidney_physiology | 1.83261383 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.80574558 |
| 40 | MP0009764_decreased_sensitivity_to | 1.79378611 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.77976879 |
| 42 | MP0001730_embryonic_growth_arrest | 1.73881438 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.71801296 |
| 44 | MP0005451_abnormal_body_composition | 1.65406043 |
| 45 | MP0002254_reproductive_system_inflammat | 1.64319599 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.63611376 |
| 47 | MP0010307_abnormal_tumor_latency | 1.61443471 |
| 48 | MP0003075_altered_response_to | 1.58795005 |
| 49 | MP0008260_abnormal_autophagy | 1.58418464 |
| 50 | MP0002405_respiratory_system_inflammati | 1.56873310 |
| 51 | MP0000490_abnormal_crypts_of | 1.54992151 |
| 52 | MP0008058_abnormal_DNA_repair | 1.53808259 |
| 53 | MP0004947_skin_inflammation | 1.52974591 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.52691534 |
| 55 | MP0000343_altered_response_to | 1.52514240 |
| 56 | MP0008004_abnormal_stomach_pH | 1.52024527 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.51507400 |
| 58 | MP0003186_abnormal_redox_activity | 1.49373776 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.48747471 |
| 60 | MP0005365_abnormal_bile_salt | 1.48126614 |
| 61 | MP0001756_abnormal_urination | 1.47206247 |
| 62 | MP0000716_abnormal_immune_system | 1.43043374 |
| 63 | MP0003828_pulmonary_edema | 1.42643517 |
| 64 | MP0005310_abnormal_salivary_gland | 1.41388587 |
| 65 | MP0005166_decreased_susceptibility_to | 1.39894503 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.39085592 |
| 67 | MP0003690_abnormal_glial_cell | 1.37995878 |
| 68 | MP0003252_abnormal_bile_duct | 1.37932220 |
| 69 | MP0008932_abnormal_embryonic_tissue | 1.35165362 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.33934814 |
| 71 | MP0003436_decreased_susceptibility_to | 1.32434307 |
| 72 | MP0004510_myositis | 1.31736645 |
| 73 | MP0001849_ear_inflammation | 1.31057611 |
| 74 | MP0000350_abnormal_cell_proliferation | 1.28493768 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.28266572 |
| 76 | MP0003941_abnormal_skin_development | 1.23548731 |
| 77 | MP0002653_abnormal_ependyma_morphology | 1.21854700 |
| 78 | MP0002398_abnormal_bone_marrow | 1.17576258 |
| 79 | MP0002396_abnormal_hematopoietic_system | 1.17400802 |
| 80 | MP0003718_maternal_effect | 1.16531365 |
| 81 | MP0004883_abnormal_blood_vessel | 1.14125535 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.14075700 |
| 83 | MP0002086_abnormal_extraembryonic_tissu | 1.11620001 |
| 84 | * MP0001697_abnormal_embryo_size | 1.11534639 |
| 85 | MP0005023_abnormal_wound_healing | 1.10428149 |
| 86 | MP0000858_altered_metastatic_potential | 1.10283928 |
| 87 | * MP0001672_abnormal_embryogenesis/_devel | 1.08915071 |
| 88 | * MP0005380_embryogenesis_phenotype | 1.08915071 |
| 89 | MP0002429_abnormal_blood_cell | 1.08102520 |
| 90 | MP0003300_gastrointestinal_ulcer | 1.07515487 |
| 91 | MP0003866_abnormal_defecation | 1.07228809 |
| 92 | MP0002796_impaired_skin_barrier | 1.07131983 |
| 93 | MP0008057_abnormal_DNA_replication | 1.06963367 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.06586536 |
| 95 | MP0000477_abnormal_intestine_morphology | 1.06341517 |
| 96 | MP0005501_abnormal_skin_physiology | 1.03047928 |
| 97 | MP0005164_abnormal_response_to | 1.02709424 |
| 98 | MP0003329_amyloid_beta_deposits | 1.01756495 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.99883258 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.99401413 |
| 101 | MP0003283_abnormal_digestive_organ | 0.99116506 |
| 102 | * MP0003984_embryonic_growth_retardation | 0.98695749 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.98558441 |
| 104 | MP0001835_abnormal_antigen_presentation | 0.98454197 |
| 105 | * MP0002088_abnormal_embryonic_growth/wei | 0.98091000 |
| 106 | * MP0002722_abnormal_immune_system | 0.97035280 |
| 107 | MP0002085_abnormal_embryonic_tissue | 0.96507017 |
| 108 | MP0002084_abnormal_developmental_patter | 0.96462080 |
| 109 | MP0010155_abnormal_intestine_physiology | 0.95109957 |
| 110 | MP0004858_abnormal_nervous_system | 0.94929002 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.94440690 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.93681303 |
| 113 | MP0002080_prenatal_lethality | 0.93621563 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.93361145 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.93049388 |
| 116 | MP0006082_CNS_inflammation | 0.92138255 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.91655450 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.91413953 |
| 119 | MP0000313_abnormal_cell_death | 0.91152386 |
| 120 | MP0002132_abnormal_respiratory_system | 0.91133061 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.90075551 |
| 122 | MP0002135_abnormal_kidney_morphology | 0.89301967 |
| 123 | MP0003890_abnormal_embryonic-extraembry | 0.88963727 |
| 124 | MP0009278_abnormal_bone_marrow | 0.87857030 |
| 125 | MP0001293_anophthalmia | 0.87804671 |
| 126 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85571850 |
| 127 | MP0009763_increased_sensitivity_to | 0.83893312 |
| 128 | MP0010329_abnormal_lipoprotein_level | 0.83815086 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.83145557 |
| 130 | MP0001764_abnormal_homeostasis | 0.82977463 |
| 131 | MP0001915_intracranial_hemorrhage | 0.82303981 |
| 132 | MP0001873_stomach_inflammation | 0.81216006 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.80790388 |
| 134 | MP0006054_spinal_hemorrhage | 0.80653806 |
| 135 | MP0003119_abnormal_digestive_system | 0.80402031 |
| 136 | MP0000598_abnormal_liver_morphology | 0.80247308 |
| 137 | MP0000249_abnormal_blood_vessel | 0.79085781 |
| 138 | MP0000537_abnormal_urethra_morphology | 0.78617943 |
| 139 | MP0000920_abnormal_myelination | 0.77065089 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.76945147 |
| 141 | MP0001851_eye_inflammation | 0.76734197 |
| 142 | MP0003315_abnormal_perineum_morphology | 0.76486833 |
| 143 | MP0001663_abnormal_digestive_system | 0.76140623 |
| 144 | * MP0000689_abnormal_spleen_morphology | 0.75756337 |
| 145 | MP0002019_abnormal_tumor_incidence | 0.75590700 |
| 146 | MP0005266_abnormal_metabolism | 0.75522422 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.75480314 |
| 148 | MP0008469_abnormal_protein_level | 0.75458088 |
| 149 | MP0001545_abnormal_hematopoietic_system | 0.75411399 |
| 150 | MP0005397_hematopoietic_system_phenotyp | 0.75411399 |
| 151 | MP0003195_calcinosis | 0.75200976 |
| 152 | MP0005390_skeleton_phenotype | 0.72762261 |
| 153 | MP0003448_altered_tumor_morphology | 0.69562256 |
| 154 | MP0001853_heart_inflammation | 0.69481003 |
| 155 | MP0003795_abnormal_bone_structure | 0.68995055 |
| 156 | MP0000609_abnormal_liver_physiology | 0.68808084 |
| 157 | MP0003879_abnormal_hair_cell | 0.66476607 |
| 158 | MP0003656_abnormal_erythrocyte_physiolo | 0.64846043 |
| 159 | MP0009765_abnormal_xenobiotic_induced | 0.64685411 |
| 160 | MP0003453_abnormal_keratinocyte_physiol | 0.64097116 |
| 161 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61070768 |
| 162 | MP0002118_abnormal_lipid_homeostasis | 0.60850681 |
| 163 | MP0008874_decreased_physiological_sensi | 0.58715325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.07192527 |
| 2 | * Abnormality of macrophages (HP:0004311) | 5.78141420 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.55478661 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.46391259 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.33482032 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.33482032 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.33482032 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.01510213 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.73211577 |
| 10 | Myositis (HP:0100614) | 4.44526369 |
| 11 | Orchitis (HP:0100796) | 4.41429675 |
| 12 | Stomatitis (HP:0010280) | 4.17121873 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.11883975 |
| 14 | Optic neuritis (HP:0100653) | 4.11883975 |
| 15 | Hyperglycinuria (HP:0003108) | 4.11621116 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.01279176 |
| 17 | Hydroxyprolinuria (HP:0003080) | 3.92794393 |
| 18 | Abnormality of proline metabolism (HP:0010907) | 3.92794393 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 3.91503765 |
| 20 | Amyloidosis (HP:0011034) | 3.87113089 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.81361320 |
| 22 | Hypomagnesemia (HP:0002917) | 3.73259868 |
| 23 | Gout (HP:0001997) | 3.67373890 |
| 24 | Abnormal urine output (HP:0012590) | 3.58446402 |
| 25 | Increased circulating renin level (HP:0000848) | 3.57721623 |
| 26 | Abnormality of magnesium homeostasis (HP:0004921) | 3.56672659 |
| 27 | Abnormality of chloride homeostasis (HP:0011422) | 3.55869309 |
| 28 | Proximal tubulopathy (HP:0000114) | 3.55201692 |
| 29 | Polyuria (HP:0000103) | 3.54360060 |
| 30 | Loss of speech (HP:0002371) | 3.53969268 |
| 31 | Abnormality of renal excretion (HP:0011036) | 3.52017146 |
| 32 | Recurrent skin infections (HP:0001581) | 3.50799214 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47479362 |
| 34 | Metabolic alkalosis (HP:0200114) | 3.40533010 |
| 35 | Reticulocytopenia (HP:0001896) | 3.38909680 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.36775986 |
| 37 | Hypokalemic alkalosis (HP:0001949) | 3.33875021 |
| 38 | Obstructive lung disease (HP:0006536) | 3.25213087 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25213087 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.20749362 |
| 41 | Metaphyseal cupping (HP:0003021) | 3.16271446 |
| 42 | Gingivitis (HP:0000230) | 3.15230456 |
| 43 | Carpal bone hypoplasia (HP:0001498) | 3.14574151 |
| 44 | Renal salt wasting (HP:0000127) | 3.09923968 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 3.07193164 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 3.05326195 |
| 47 | Disinhibition (HP:0000734) | 3.03969449 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 3.01712665 |
| 49 | Vasculitis (HP:0002633) | 2.99416377 |
| 50 | Gingival bleeding (HP:0000225) | 2.98436362 |
| 51 | Meningitis (HP:0001287) | 2.96727011 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.96043283 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.91485297 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.89628616 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.89628616 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86702707 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86702707 |
| 58 | Increased purine levels (HP:0004368) | 2.86320672 |
| 59 | Hyperuricemia (HP:0002149) | 2.86320672 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.84953876 |
| 61 | Petechiae (HP:0000967) | 2.83027928 |
| 62 | Urticaria (HP:0001025) | 2.82422821 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.82036512 |
| 64 | Agnosia (HP:0010524) | 2.80775067 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79010123 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79010123 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79010123 |
| 68 | Encephalitis (HP:0002383) | 2.78232540 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.77625030 |
| 70 | Hemoptysis (HP:0002105) | 2.77155533 |
| 71 | Mutism (HP:0002300) | 2.67221033 |
| 72 | Hypercalciuria (HP:0002150) | 2.61473719 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.58840707 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53302852 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.53051689 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.52612050 |
| 77 | Glycosuria (HP:0003076) | 2.52612050 |
| 78 | * Malnutrition (HP:0004395) | 2.50417227 |
| 79 | Alkalosis (HP:0001948) | 2.48158770 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.47864439 |
| 81 | Purpura (HP:0000979) | 2.47463322 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.45991107 |
| 83 | Polydipsia (HP:0001959) | 2.45991107 |
| 84 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.45415395 |
| 85 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42713857 |
| 86 | Episodic fever (HP:0001954) | 2.41848847 |
| 87 | Tetany (HP:0001281) | 2.41190763 |
| 88 | Pustule (HP:0200039) | 2.38883455 |
| 89 | Recurrent viral infections (HP:0004429) | 2.38725607 |
| 90 | Hematochezia (HP:0002573) | 2.37711398 |
| 91 | Macrocytic anemia (HP:0001972) | 2.35807899 |
| 92 | Polyneuropathy (HP:0001271) | 2.34212875 |
| 93 | Dehydration (HP:0001944) | 2.33309142 |
| 94 | Abnormal trabecular bone morphology (HP:0100671) | 2.32720640 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32563864 |
| 96 | Epistaxis (HP:0000421) | 2.32287369 |
| 97 | T lymphocytopenia (HP:0005403) | 2.31677932 |
| 98 | Rough bone trabeculation (HP:0100670) | 2.31401939 |
| 99 | Leukocytosis (HP:0001974) | 2.30819537 |
| 100 | Abnormality of T cell number (HP:0011839) | 2.25380575 |
| 101 | Mesangial abnormality (HP:0001966) | 2.24710663 |
| 102 | Cellulitis (HP:0100658) | 2.24071179 |
| 103 | Nephrolithiasis (HP:0000787) | 2.23501935 |
| 104 | Chest pain (HP:0100749) | 2.23343353 |
| 105 | Myocardial infarction (HP:0001658) | 2.23072140 |
| 106 | Osteomyelitis (HP:0002754) | 2.21397893 |
| 107 | Delayed epiphyseal ossification (HP:0002663) | 2.20930187 |
| 108 | Multiple enchondromatosis (HP:0005701) | 2.19931197 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18192926 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.18167882 |
| 111 | Joint swelling (HP:0001386) | 2.18034105 |
| 112 | Rhabdomyosarcoma (HP:0002859) | 2.17392320 |
| 113 | Premature loss of primary teeth (HP:0006323) | 2.17356089 |
| 114 | Increased IgM level (HP:0003496) | 2.16832209 |
| 115 | Spastic diplegia (HP:0001264) | 2.16341438 |
| 116 | Increased IgE level (HP:0003212) | 2.16186291 |
| 117 | Ileus (HP:0002595) | 2.15996476 |
| 118 | Anorexia (HP:0002039) | 2.15335033 |
| 119 | Inflammation of the large intestine (HP:0002037) | 2.14610023 |
| 120 | Glomerulonephritis (HP:0000099) | 2.10971751 |
| 121 | Hyperphosphaturia (HP:0003109) | 2.10661158 |
| 122 | Arterial thrombosis (HP:0004420) | 2.10635349 |
| 123 | Widely patent fontanelles and sutures (HP:0004492) | 2.10527655 |
| 124 | Prolonged bleeding time (HP:0003010) | 2.09968605 |
| 125 | Chronic diarrhea (HP:0002028) | 2.09338432 |
| 126 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.07858198 |
| 127 | Ependymoma (HP:0002888) | 2.07262927 |
| 128 | Abnormality of renin-angiotensin system (HP:0000847) | 2.06123645 |
| 129 | High anterior hairline (HP:0009890) | 2.05961598 |
| 130 | Abdominal situs inversus (HP:0003363) | 2.04643926 |
| 131 | Abnormality of abdominal situs (HP:0011620) | 2.04643926 |
| 132 | Pulmonary embolism (HP:0002204) | 2.04545103 |
| 133 | Progressive neurologic deterioration (HP:0002344) | 2.04534078 |
| 134 | Breast hypoplasia (HP:0003187) | 2.02889960 |
| 135 | Colon cancer (HP:0003003) | 2.02485283 |
| 136 | Hepatosplenomegaly (HP:0001433) | 2.02424383 |
| 137 | Abnormal urine phosphate concentration (HP:0012599) | 2.02327098 |
| 138 | Trismus (HP:0000211) | 2.00959244 |
| 139 | Gastrointestinal inflammation (HP:0004386) | 1.99985287 |
| 140 | Hyponatremia (HP:0002902) | 1.99414556 |
| 141 | Colitis (HP:0002583) | 1.99194537 |
| 142 | Recurrent pneumonia (HP:0006532) | 1.98361688 |
| 143 | Renal tubular acidosis (HP:0001947) | 1.97516294 |
| 144 | IgM deficiency (HP:0002850) | 1.97024531 |
| 145 | Retinal atrophy (HP:0001105) | 1.96404115 |
| 146 | Degeneration of anterior horn cells (HP:0002398) | 1.95983282 |
| 147 | Abnormality of the anterior horn cell (HP:0006802) | 1.95983282 |
| 148 | Gangrene (HP:0100758) | 1.95163049 |
| 149 | Hyperaldosteronism (HP:0000859) | 1.94680914 |
| 150 | Short humerus (HP:0005792) | 1.94644576 |
| 151 | Flat acetabular roof (HP:0003180) | 1.91908781 |
| 152 | Neurofibrillary tangles (HP:0002185) | 1.91888032 |
| 153 | Restrictive lung disease (HP:0002091) | 1.91848293 |
| 154 | Abnormality of the pleura (HP:0002103) | 1.91636640 |
| 155 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91350491 |
| 156 | * Increased serum ferritin (HP:0003281) | 1.91079224 |
| 157 | Gastrointestinal stroma tumor (HP:0100723) | 1.90267901 |
| 158 | Complement deficiency (HP:0004431) | 1.88342822 |
| 159 | Neuronal loss in central nervous system (HP:0002529) | 1.87554088 |
| 160 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.87371311 |
| 161 | Urethral obstruction (HP:0000796) | 1.87309374 |
| 162 | Metaphyseal irregularity (HP:0003025) | 1.86955847 |
| 163 | Increased CSF protein (HP:0002922) | 1.86542484 |
| 164 | Axonal loss (HP:0003447) | 1.86045640 |
| 165 | Birth length less than 3rd percentile (HP:0003561) | 1.85801645 |
| 166 | Confusion (HP:0001289) | 1.83749549 |
| 167 | Vertigo (HP:0002321) | 1.83412305 |
| 168 | Tubular atrophy (HP:0000092) | 1.83084776 |
| 169 | Dysostosis multiplex (HP:0000943) | 1.83016167 |
| 170 | Oral leukoplakia (HP:0002745) | 1.82387973 |
| 171 | Abnormality of reticulocytes (HP:0004312) | 1.80326778 |
| 172 | Abnormality of T cells (HP:0002843) | 1.80221735 |
| 173 | Hypergammaglobulinemia (HP:0010702) | 1.79480545 |
| 174 | Hypophosphatemia (HP:0002148) | 1.78448280 |
| 175 | Spinal muscular atrophy (HP:0007269) | 1.77603745 |
| 176 | Rectal fistula (HP:0100590) | 1.77435138 |
| 177 | Rectovaginal fistula (HP:0000143) | 1.77435138 |
| 178 | Vaginal fistula (HP:0004320) | 1.76993025 |
| 179 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76886685 |
| 180 | Mucopolysacchariduria (HP:0008155) | 1.76886685 |
| 181 | Abnormality of the costochondral junction (HP:0000919) | 1.75433466 |
| 182 | Pathologic fracture (HP:0002756) | 1.75036349 |
| 183 | Esophageal varix (HP:0002040) | 1.74532412 |
| 184 | Biliary tract neoplasm (HP:0100574) | 1.73692830 |
| 185 | Rickets (HP:0002748) | 1.73486380 |
| 186 | Hypokalemia (HP:0002900) | 1.73133408 |
| 187 | Muscle fibrillation (HP:0010546) | 1.72851608 |
| 188 | Abnormality of sodium homeostasis (HP:0010931) | 1.72716734 |
| 189 | Tongue fasciculations (HP:0001308) | 1.70717543 |
| 190 | Nephrocalcinosis (HP:0000121) | 1.68244881 |
| 191 | Vascular calcification (HP:0004934) | 1.66309102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.59992309 |
| 2 | MST4 | 2.85825639 |
| 3 | BUB1 | 2.78862303 |
| 4 | CSK | 2.69312044 |
| 5 | IRAK4 | 2.51494879 |
| 6 | CDK12 | 2.48316428 |
| 7 | STK10 | 2.39688107 |
| 8 | NEK1 | 2.34119218 |
| 9 | FGR | 2.31297328 |
| 10 | WNK3 | 2.28334508 |
| 11 | PRPF4B | 2.12206788 |
| 12 | WNK4 | 2.11221649 |
| 13 | WEE1 | 2.06122623 |
| 14 | TSSK6 | 2.00683399 |
| 15 | TTK | 1.94691452 |
| 16 | FES | 1.94510471 |
| 17 | PAK4 | 1.89491856 |
| 18 | CDC7 | 1.89382929 |
| 19 | EIF2AK1 | 1.80163465 |
| 20 | ERN1 | 1.76904780 |
| 21 | JAK3 | 1.75444032 |
| 22 | TXK | 1.71655932 |
| 23 | FLT3 | 1.70419399 |
| 24 | PDK2 | 1.68649077 |
| 25 | NME2 | 1.67319488 |
| 26 | MAP3K13 | 1.66601369 |
| 27 | IKBKE | 1.66302453 |
| 28 | SYK | 1.60364996 |
| 29 | CSF1R | 1.58540346 |
| 30 | TGFBR2 | 1.56848436 |
| 31 | RPS6KB2 | 1.55756603 |
| 32 | TAOK3 | 1.55228809 |
| 33 | MAP3K8 | 1.52219860 |
| 34 | GRK6 | 1.51899044 |
| 35 | TESK2 | 1.49262535 |
| 36 | TAOK1 | 1.46016157 |
| 37 | TYK2 | 1.45473103 |
| 38 | STK38L | 1.43751509 |
| 39 | JAK1 | 1.43330469 |
| 40 | MATK | 1.41728565 |
| 41 | CDK7 | 1.41600327 |
| 42 | TNK2 | 1.40603859 |
| 43 | LYN | 1.40213394 |
| 44 | TGFBR1 | 1.39801749 |
| 45 | MAPKAPK3 | 1.39020929 |
| 46 | BCKDK | 1.35774061 |
| 47 | MAP2K2 | 1.33749243 |
| 48 | GRK7 | 1.31295101 |
| 49 | PIK3CG | 1.30301286 |
| 50 | KDR | 1.30260418 |
| 51 | OXSR1 | 1.29797948 |
| 52 | FRK | 1.27571040 |
| 53 | BMPR2 | 1.27121275 |
| 54 | HCK | 1.26962351 |
| 55 | MAP3K1 | 1.24347773 |
| 56 | LRRK2 | 1.24178659 |
| 57 | PIM1 | 1.23392052 |
| 58 | NEK2 | 1.23328888 |
| 59 | MAP2K3 | 1.21386317 |
| 60 | PRKCI | 1.21078471 |
| 61 | JAK2 | 1.18379187 |
| 62 | PRKG2 | 1.17228378 |
| 63 | EPHB1 | 1.16792489 |
| 64 | MAP3K10 | 1.12135967 |
| 65 | KIT | 1.10304633 |
| 66 | IRAK3 | 1.09517930 |
| 67 | CDC42BPA | 1.08468100 |
| 68 | LCK | 1.07261359 |
| 69 | MAP3K3 | 1.06946718 |
| 70 | MAP4K1 | 1.05594880 |
| 71 | MAP3K11 | 1.03595402 |
| 72 | TAOK2 | 1.02783087 |
| 73 | PKN2 | 1.02273623 |
| 74 | MAP3K14 | 1.01962698 |
| 75 | PIM2 | 1.01178198 |
| 76 | SCYL2 | 1.00506884 |
| 77 | MARK3 | 0.99690706 |
| 78 | PDPK1 | 0.99251668 |
| 79 | SIK3 | 0.97551045 |
| 80 | PDK1 | 0.95238333 |
| 81 | PLK1 | 0.93428165 |
| 82 | TLK1 | 0.91984384 |
| 83 | AURKB | 0.91129024 |
| 84 | IRAK1 | 0.88715263 |
| 85 | TESK1 | 0.86308807 |
| 86 | ITK | 0.84231924 |
| 87 | EIF2AK3 | 0.83631978 |
| 88 | VRK1 | 0.82919326 |
| 89 | BLK | 0.80690820 |
| 90 | CDK6 | 0.79597918 |
| 91 | AURKA | 0.79518191 |
| 92 | ABL2 | 0.77674920 |
| 93 | PTK2 | 0.77130751 |
| 94 | IRAK2 | 0.75409336 |
| 95 | MET | 0.73677522 |
| 96 | ACVR1B | 0.73347255 |
| 97 | DDR2 | 0.72888006 |
| 98 | TEC | 0.71953431 |
| 99 | LMTK2 | 0.71649388 |
| 100 | CDK4 | 0.71019341 |
| 101 | STK4 | 0.70637671 |
| 102 | ATR | 0.70028570 |
| 103 | PTK6 | 0.69488410 |
| 104 | RIPK4 | 0.68024687 |
| 105 | EEF2K | 0.67944012 |
| 106 | YES1 | 0.67520088 |
| 107 | ALK | 0.65965161 |
| 108 | MST1R | 0.64346637 |
| 109 | CAMKK2 | 0.64148939 |
| 110 | MAP3K5 | 0.63382182 |
| 111 | PDK4 | 0.62798149 |
| 112 | PDK3 | 0.62798149 |
| 113 | MAPK7 | 0.62606526 |
| 114 | RIPK1 | 0.61804765 |
| 115 | DAPK2 | 0.61283126 |
| 116 | PLK3 | 0.61117289 |
| 117 | CDK19 | 0.59437449 |
| 118 | BRSK2 | 0.57896104 |
| 119 | LATS2 | 0.57696989 |
| 120 | ADRBK2 | 0.57619943 |
| 121 | FGFR4 | 0.57271034 |
| 122 | FYN | 0.55284239 |
| 123 | BRD4 | 0.55022233 |
| 124 | CHUK | 0.54846981 |
| 125 | RPS6KA4 | 0.54314057 |
| 126 | MAPK12 | 0.52609192 |
| 127 | PRKCQ | 0.51150097 |
| 128 | MTOR | 0.50508216 |
| 129 | PAK1 | 0.50405468 |
| 130 | AKT3 | 0.48814668 |
| 131 | MOS | 0.48792944 |
| 132 | MAP2K6 | 0.46823609 |
| 133 | NEK9 | 0.46527538 |
| 134 | EPHA3 | 0.45991997 |
| 135 | TBK1 | 0.45089774 |
| 136 | FGFR3 | 0.44512846 |
| 137 | MARK2 | 0.44011818 |
| 138 | PASK | 0.43828006 |
| 139 | KSR2 | 0.42700085 |
| 140 | PLK4 | 0.42699879 |
| 141 | MELK | 0.42556989 |
| 142 | CHEK2 | 0.41711424 |
| 143 | IKBKB | 0.41612781 |
| 144 | CHEK1 | 0.41471530 |
| 145 | CSNK2A2 | 0.41102632 |
| 146 | MAP3K2 | 0.40558681 |
| 147 | PRKD2 | 0.39211189 |
| 148 | NME1 | 0.37945777 |
| 149 | BTK | 0.36753700 |
| 150 | NLK | 0.36202123 |
| 151 | ATM | 0.35260220 |
| 152 | ABL1 | 0.34970943 |
| 153 | PRKCD | 0.33991758 |
| 154 | RPS6KC1 | 0.33162186 |
| 155 | RPS6KL1 | 0.33162186 |
| 156 | STK24 | 0.32893468 |
| 157 | ZAP70 | 0.32814083 |
| 158 | SGK3 | 0.31862789 |
| 159 | CDK2 | 0.31165554 |
| 160 | DYRK1B | 0.31013719 |
| 161 | PRKCZ | 0.28643892 |
| 162 | CAMK1D | 0.27709908 |
| 163 | RPS6KA6 | 0.27163803 |
| 164 | EGFR | 0.25678204 |
| 165 | ARAF | 0.24651493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.03972767 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.74498385 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.72544884 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68150742 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62323949 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.62290093 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.55464851 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.42110422 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.36355738 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.36088101 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.35673598 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.20982816 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.19092048 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.13502087 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12539803 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11204860 |
| 17 | Mineral absorption_Homo sapiens_hsa04978 | 2.10281715 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06427170 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05892071 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00328754 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.98574628 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96483962 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.95591872 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.93514867 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81391566 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72732915 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71927731 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67461710 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.67222614 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.65467341 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59690876 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.57322647 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.56179985 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.56029376 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.55927696 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.55535488 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.54789915 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52943125 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49424991 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49064063 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.48036117 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45498854 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44530048 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42534030 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 1.39677155 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37520194 |
| 47 | Spliceosome_Homo sapiens_hsa03040 | 1.37329835 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37113963 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35125483 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32741787 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31007799 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30204431 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29919574 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29123732 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28422265 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26322057 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25939591 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24234614 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23616059 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22788731 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21281492 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 1.16419808 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14235350 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11457407 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09955268 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 1.09298256 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07949333 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07913613 |
| 69 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06392047 |
| 70 | Measles_Homo sapiens_hsa05162 | 1.02744600 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99959790 |
| 72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.99618551 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.99519595 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98972355 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98099469 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98092553 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96013803 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95957857 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95517527 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92571479 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.92044877 |
| 82 | Cell cycle_Homo sapiens_hsa04110 | 0.91833212 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91759931 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91637653 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88752199 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88194140 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88013166 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87399851 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87029832 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86008668 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79985049 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79370955 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77811958 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77520180 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.76889444 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74417910 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70588703 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69839014 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.67745797 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.66989835 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.65380176 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65224848 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.64887020 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64664319 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64571003 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.63852641 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63211281 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62864102 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.62045265 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61690685 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60377679 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.60315594 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58629108 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58601214 |
| 115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58088444 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57829170 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56020928 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55976804 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55571962 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50758597 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49646839 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48446558 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48112095 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47913071 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.47817954 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.46874459 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46116113 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45894192 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44780443 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.43172797 |
| 131 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42755234 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.42258115 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42129470 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42105604 |
| 135 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41952055 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41030806 |
| 137 | Influenza A_Homo sapiens_hsa05164 | 0.39428179 |
| 138 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39126876 |
| 139 | RNA degradation_Homo sapiens_hsa03018 | 0.38182399 |
| 140 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37648683 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37409780 |
| 142 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35698802 |
| 143 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35064246 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34900845 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.33960011 |
| 146 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33637334 |
| 147 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33377878 |
| 148 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33219743 |
| 149 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33147684 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32716866 |
| 151 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32577681 |
| 152 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32237350 |
| 153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31385493 |
| 154 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31303410 |
| 155 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31258102 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | 0.31073382 |
| 157 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30309082 |
| 158 | Insulin resistance_Homo sapiens_hsa04931 | 0.30083651 |
| 159 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29993731 |
| 160 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27300303 |
| 161 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24990009 |
| 162 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21553057 |
| 163 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20290481 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20262993 |

